Florence Dalenc

Florence Dalenc

UNVERIFIED PROFILE

Are you Florence Dalenc?   Register this Author

Register author
Florence Dalenc

Florence Dalenc

Publications by authors named "Florence Dalenc"

Are you Florence Dalenc?   Register this Author

84Publications

2120Reads

13Profile Views

Long-Term Follow-up of Immediate Latissimus Dorsi Flap Reconstruction After Neoadjuvant Chemotherapy and Radiotherapy for Invasive Breast Cancer.

Clin Breast Cancer 2019 Aug 17;19(4):e540-e546. Epub 2019 Apr 17.

Department of Oncological Surgery, Toulouse University Hospital, Toulouse University Cancer Institute-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2019.03.007DOI Listing
August 2019

A fast UPLC-HILIC method for an accurate quantification of dendrogenin A in human tissues.

J Steroid Biochem Mol Biol 2019 Aug 12:105447. Epub 2019 Aug 12.

Team "Dose individualization of anticancer drugs », Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France; Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse, France; Service d'Anatomo-Pathologie, Centre Hospitalier Universitaire de Toulouse, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2019.105447DOI Listing
August 2019

Work adjustments and employment among breast cancer survivors: a French prospective study.

Support Care Cancer 2019 Apr 17. Epub 2019 Apr 17.

Service des Maladies Professionnelles et Environnementales, CHU Toulouse, F-31000, Toulouse, France.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s00520-019-04799-w
Publisher Site
http://dx.doi.org/10.1007/s00520-019-04799-wDOI Listing
April 2019

The Protease-Dependent Mesenchymal Migration of Tumor-Associated Macrophages as a Target in Cancer Immunotherapy.

Cancer Immunol Res 2018 11 4;6(11):1337-1351. Epub 2018 Sep 4.

Institut de Pharmacologie et Biologie Structurale, IPBS, Université de Toulouse, CNRS, UPS, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-17-0746DOI Listing
November 2018

Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite.

Biochimie 2018 Oct 12;153:139-149. Epub 2018 Apr 12.

Cancer Research Center of Toulouse, UMR 1037 INSERM-University of Toulouse, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03009084183009
Publisher Site
http://dx.doi.org/10.1016/j.biochi.2018.04.008DOI Listing
October 2018

Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report.

Clin Breast Cancer 2018 10 18;18(5):e743-e746. Epub 2018 Jun 18.

Department of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2018.06.009DOI Listing
October 2018

Focus on an infrequently used quantity in the context of competing risks: The conditional probability function.

Comput Biol Med 2018 10 4;101:70-81. Epub 2018 Aug 4.

Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2018.08.002DOI Listing
October 2018

The Effects of Cholesterol-Derived Oncometabolites on Nuclear Receptor Function in Cancer.

Cancer Res 2018 Sep 17;78(17):4803-4808. Epub 2018 Aug 17.

Cholesterol Metabolism and Therapeutic Innovations, Cancer Research Center of Toulouse (CRCT), UMR 1037, Université de Toulouse, CNRS, Inserm, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-18-1487DOI Listing
September 2018

[Nomograms in routine clinical practice: Methodology, interest and limitations].

Bull Cancer 2018 Jan 6;105(1):15-24. Epub 2017 Dec 6.

Institut Claudius-Regaud, IUCT-oncopole, département de chirurgie, 1, avenue Irène-Joliot-Curie, 31059 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bulcan.2017.10.024DOI Listing
January 2018

Breast tumours

Rev Prat 2017 11;67(9):e445-e454

Institut Claudius-Regaud, institut universitaire du cancer, Toulouse, France.PU-PH oncologie médicale.

View Article

Download full-text PDF

Source
November 2017

Impact of surgery on survival in stage IV breast cancer.

Breast J 2017 11 15;23(6):774. Epub 2017 May 15.

Medical Oncology, IUCT-Oncopole, Institut Claudius Regaud, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12822DOI Listing
November 2017

Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death.

Biochem Pharmacol 2017 11 19;144:18-28. Epub 2017 Jun 19.

Cancer Research Center of Toulouse, UMR 1037INSERM-University of Toulouse, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bcp.2017.06.120DOI Listing
November 2017

Breast cancer diagnostic assessment

Rev Prat 2017 Nov;67(9):e453-e454

Institut Claudius-Regaud, institut universitaire du cancer, Toulouse, France

View Article

Download full-text PDF

Source
November 2017

Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study.

J Steroid Biochem Mol Biol 2017 05 22;169:210-218. Epub 2016 Jun 22.

Inserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France; University of Toulouse III, Toulouse France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jsbmb.2016.06.010DOI Listing
May 2017

Daily Practice Management of pT1a-b pN0 Breast Carcinoma: A Prospective French ODISSEE Cohort Study.

Clin Breast Cancer 2017 Apr 31;17(2):107-116. Epub 2016 Aug 31.

Assistance Publique Hôpitaux de Paris (AP-HP), Department of Radiation Oncology and Henri Mondor Breast Center, INSERM U955 E07, and University of Paris-Est Créteil (UPEC), France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clbc.2016.08.007DOI Listing
April 2017

External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.

Eur J Cancer 2017 02 30;72:200-209. Epub 2016 Dec 30.

Department of Medical Oncology, Institut Claudius Regaud, IUCT-O, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.10.019DOI Listing
February 2017

Outcome of pN0 Triple-Negative Breast Cancer with or without Lymph Node Irradiation: A Single Institution Experience.

Breast J 2016 Sep 4;22(5):510-9. Epub 2016 Jun 4.

Department of Radiation Oncology, Institut Claudius Regaud / Institut Universitaire du Cancer de Toulouse - Oncopôle, Toulouse, Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/tbj.12626DOI Listing
September 2016

Dendrogenin A: A Mammalian Metabolite of Cholesterol with Tumor Suppressor and Neurostimulating Properties.

Curr Med Chem 2015 ;22(30):3533-49

Department of Sterol Metabolism, Cancer Research Center of Toulouse, INSERM UMR 1037-University of Toulouse, P.O. Box: 31017, Toulouse, France.

View Article

Download full-text PDF

Source
June 2016

Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases.

Breast Cancer Res Treat 2016 06 11;157(2):307-318. Epub 2016 May 11.

Medical Oncology Department, Institut Claudius Regaud, IUCT-Oncopole, 1 avenue Irène Joliot-Curie, 31059, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-016-3828-6DOI Listing
June 2016

Oncologic surveillance after curative treatment: A probability-based approach should be preferred to a risk-based approach.

Urol Oncol 2016 May 30;34(5):244-5. Epub 2016 Mar 30.

Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse-Oncopole, Toulouse, France. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S10781439160008
Publisher Site
http://dx.doi.org/10.1016/j.urolonc.2016.02.026DOI Listing
May 2016

Tamoxifen and ovarian function.

PLoS One 2013 28;8(6):e66616. Epub 2013 Jun 28.

Clinique du sein, Centre du Cancer, Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0066616PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3695994PMC
January 2014

RhoA and RhoC differentially modulate estrogen receptor α recruitment, transcriptional activities, and expression in breast cancer cells (MCF-7).

J Cancer Res Clin Oncol 2013 Dec 6;139(12):2079-88. Epub 2013 Oct 6.

INSERM U563 and UMR1037, Institut Claudius Regaud, 20-24 rue du pont St Pierre, 31052, Toulouse Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-013-1533-yDOI Listing
December 2013

[Medical treatment of breast cancer: chemotherapy and tailored therapy].

Authors:
Florence Dalenc

Rev Prat 2013 Dec;63(10):1408-14

Institut Claudius-Regaud, 31052 Toulouse Cedex, France.

View Article

Download full-text PDF

Source
December 2013

Targeting FGFR with dovitinib (TKI258): preclinical and clinical data in breast cancer.

Clin Cancer Res 2013 Jul 8;19(13):3693-702. Epub 2013 May 8.

Department of Medical Oncology, INSERM Unit U981, Paris Sud University, Institut Gustave-Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0190DOI Listing
July 2013

Importance of cholesterol and oxysterols metabolism in the pharmacology of tamoxifen and other AEBS ligands.

Chem Phys Lipids 2011 Sep 27;164(6):432-7. Epub 2011 May 27.

Cancer Research Center of Toulouse, UMR 1037 Inserm-University of Toulouse III, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.chemphyslip.2011.05.005DOI Listing
September 2011

[Medical treatments of endocrine-sensitive Her-2 negative breast cancers: a review].

Bull Cancer 2011 Jun;98(6):655-70

Institut Bergonié, département d'oncologie médicale, Bordeaux Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1684/bdc.2011.1367DOI Listing
June 2011

Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies?

J Biomed Biotechnol 2011 6;2011:856985. Epub 2010 Dec 6.

IRCM, Institut de Recherche en Cancérologie de Montpellier, INSERM, U896, Université Montpellier1, CRLC Val d'Aurelle Paul Lamarque, Montpellier, 34298, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2011/856985DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004450PMC
May 2011

Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth.

Cancer Res 2009 Nov 13;69(21):8332-40. Epub 2009 Oct 13.

Institut National de la Sante et de la Recherche Medicale U563, Institut Claudius Regaud, and Université de Toulouse, UPS, Centre de Physiopathologie de Toulouse Purpan, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-2206DOI Listing
November 2009

[Breast cancers].

Authors:
Florence Dalenc

Rev Infirm 2008 Apr(139):14-5

Médecin oncologue, CLCC Claudius-Régaud, Toulouse.

View Article

Download full-text PDF

Source
April 2008

Decision-making and breast cancer clinical trials: how experience challenges attitudes.

Contemp Clin Trials 2007 Nov 12;28(6):684-94. Epub 2007 Mar 12.

INSERM, UMR379, Epidemiology and Social Sciences Unit, Paoli-Calmettes Institute, Marseille, F-13273, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cct.2007.03.001DOI Listing
November 2007

Farnesyl-transferase inhibitor R115,777 enhances tamoxifen inhibition of MCF-7 cell growth through estrogen receptor dependent and independent pathways.

Breast Cancer Res 2005 21;7(6):R1159-67. Epub 2005 Nov 21.

INSERM U563, CPTP, Département Innovation Thérapeutique et Oncologie Moléculaire, Toulouse F-31052, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/bcr1357DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1410750PMC
February 2006

Ototoxicity of high-dose carboplatin.

J Clin Oncol 2005 May;23(15):3649-50; author reply 3650-1

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2005.05.348DOI Listing
May 2005

A recombinant cell bioassay for measurement of overall estrogenic activity of serum: preliminary results in women with breast cancer.

Clin Chem Lab Med 2004 ;42(8):889-95

Inserm U563, Centre de Physiopathologie de Toulouse Purpan, Département Innovation Thérapeutique et Oncologie Moléculaire, Institut Claudius Regaud, Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1515/CCLM.2004.144DOI Listing
February 2005

Dexamethasone as a probe for docetaxel clearance.

Cancer Chemother Pharmacol 2004 Sep 5;54(3):265-72. Epub 2004 May 5.

Institut Claudius-Regaud, Université Paul-Sabatier, 31052 Toulouse, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-004-0823-0DOI Listing
September 2004

RhoB controls the 24 kDa FGF-2-induced radioresistance in HeLa cells by preventing post-mitotic cell death.

Oncogene 2002 Sep;21(39):5998-6006

Oncologie Cellulaire et Moléculaire, INSERM U563, Département d'Innovation thérapeutique et Oncologie Moléculaire, Centre de Lutte Contre le Cancer Claudius Regaud, 20-24 rue du Pont St Pierre, 31052 Toulouse Cedex, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205746DOI Listing
September 2002